Spirogermanium
Alternative Names: NSC 192965; Spiro-32Latest Information Update: 25 Jul 1995
At a glance
- Originator Unimed Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Rheumatic disorders
Most Recent Events
- 25 Jul 1995 Discontinued-II for Rheumatic disorders in USA (Unknown route)
- 21 Jul 1995 Discontinued-II for Rheumatoid arthritis in USA (Unknown route)